The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that ...

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and ...

The White House on Friday said Novo Nordisk’s weight-loss drugs Wegovy and Ozempic were among the 15 medications picked for a ...

Novo Nordisk’s blockbuster GLP-1 medications Ozempic and Wegovy are among ... According to CMS, about 5.3 million people with Medicare Part D coverage used these medications between November ...

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic top the list of 15 drugs selected for the second round of ...

Topping the list are Novo Nordisk's blockbuster diabetes injection Ozempic, weight loss shot ... About 5.3 million people with Medicare Part D coverage used the 15 drugs in the second round ...

Ozempic and Wegovy ... Trump administration’s approach to the negotiation process and the type of Medicare drug coverage an enrollee has. Those not eligible for Medicare will not benefit ...

Those drugs are: Ozempic/Wegovy/Rybelsus ... About 5.3 million people with Medicare prescription drug coverage used these medications from November 2023 through October 2024 at a cost of $ ...